Industry
Key areas of interest include circadian rhythms, neurological conditions, metabolic disorders, and oncology.
During IPC 2024, George Paraskevakos shared recent updates on market developments and an overview of the Biotic-related survey.
VOWST is the first and only orally administered microbiota-based therapeutic approved by the U.S. FDA for the prevention of recurrent Clostridioides difficile infection in adults.
The report summarizes numerous presentations on the skin microbiome, covering topics such as acne, anti-aging, atopic dermatitis, and "microbiome-friendly" cosmetics.
The product, based on the pioneering research of Dr. Jacques Ravel, is the first of its kind to be clinically validated for establishing an optimal vaginal microbiome, dominated by Lactobacillus…
Industry
Sponsored by
The company was honored with the Ingredient of the Year award in the Microbiome Modulation and the Beauty from Within category.
Bi104 is a microbiome-modifying biologic designed to diversify and modulate the gut microflora and metabolite profile.
AB-Biotics recently appointed to the IPA board of directors. What opportunities and future developments? We discussed this with Miquel Bonachera.
Industry
Sponsored by
Join SynBalance at Vitafoods Europe 2024, held at Palexpo, Switzerland from May 14th to May 16th.
This unprecedented partnership signifies a concerted effort to address pressing microbiome-related challenges and advance health equity worldwide.
